| Authors: |
Whyte CE; Immunology Programme, The Babraham Institute, Cambridge, UK., Singh K; Immunology Programme, The Babraham Institute, Cambridge, UK., Burton OT; Immunology Programme, The Babraham Institute, Cambridge, UK.; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium., Aloulou M; Immunology Programme, The Babraham Institute, Cambridge, UK.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Centre national de la recherche scientifique U5051, Institut national de la santé et de la recherche médicale U1291, University of Toulouse III, Toulouse, France., Kouser L; Immunology Programme, The Babraham Institute, Cambridge, UK., Veiga RV; Immunology Programme, The Babraham Institute, Cambridge, UK., Dashwood A; Immunology Programme, The Babraham Institute, Cambridge, UK., Okkenhaug H; Imaging Facility, The Babraham Institute, Cambridge, UK., Benadda S; Immunology Programme, The Babraham Institute, Cambridge, UK.; Centre de Recherche Sur L'inflammation, Centre national de la recherche scientifique ERL8252, Institut national de la santé et de la recherche médicale U1149, Université de Paris, Paris, France., Moudra A; Immunology Programme, The Babraham Institute, Cambridge, UK., Bricard O; Immunology Programme, The Babraham Institute, Cambridge, UK., Lienart S; Immunology Programme, The Babraham Institute, Cambridge, UK., Bielefeld P; Immunology Programme, The Babraham Institute, Cambridge, UK., Roca CP; Immunology Programme, The Babraham Institute, Cambridge, UK., Naranjo-Galindo FJ; Immunology Programme, The Babraham Institute, Cambridge, UK., Lombard-Vadnais F; Department of Microbiology and Immunology, McGill University, Montréal, Quebec, Canada.; Department of Immunology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Quebec, Canada., Junius S; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium., Bending D; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Ono MM; Department of Life Sciences, Imperial College London, London, UK, Hochepied T; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; VIB Center for Inflammation Research, Vlaams Instituut voor Biotechnologie, Ghent, Belgium., Halim TYF; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Schlenner S; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium., Lesage S; Centre de Recherche Sur L'inflammation, Centre national de la recherche scientifique ERL8252, Institut national de la santé et de la recherche médicale U1149, Université de Paris, Paris, France.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Quebec, Canada., Dooley J; Immunology Programme, The Babraham Institute, Cambridge, UK.; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium., Liston A; Immunology Programme, The Babraham Institute, Cambridge, UK.; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium. |
